BioRestorative Therapies, Inc. (BRTX) — Dilution Risk Analysis

Current Snapshot

BioRestorative Therapies, Inc. (BRTX) has a DilutionWatch score of 77/10 and is classified as CRITICAL risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
25,478,170 Source
Public Float
24,175,216 Source
Float as % of Outstanding
94.9%

Dilution Risk Score

Score: 77/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

1 shelf registration or ATM offering filing detected in recent history.

Recent filing forms in the source payload: 424B3 1, EFFECT 2, 8-K 1, S-1/A 1, S-1 1, XBRL 2.

FormFiledAccession
424B3 2026-04-30 0001493152-26-020495
EFFECT 2026-04-28 9999999995-26-001353
8-K 2026-02-17 0001493152-26-006837
EFFECT 2026-02-11 9999999995-26-000543
S-1/A 2026-02-10 0001493152-26-006012
S-1 2026-02-09 0001493152-26-005827
xbrl 2025-12-31 xbrl-7099-xbrl_warrant
xbrl 2021-12-31 xbrl-7099-xbrl_convertible

Dilution Risk Drivers

DriverStored ValueSource
Shelf registration capacity $10,000,000 Source
ATM offering capacity remaining $5,437,500 Source
Cash runway 3 months Source
Three-year share count growth 441.29% Source

DilutionWatch Analysis

Risk Level
CRITICAL (Score: 77/10) Source
Cash Runway
3 months Source
ATM Offering Capacity Remaining
$5,437,500 Source
Shelf Registration Capacity
$10,000,000 Source
Share Count Growth (3-Year)
441.29% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.